| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2012 | US20120015984 Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients |
| 01/19/2012 | US20120015983 Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine |
| 01/19/2012 | US20120015982 Thiazolidinedione analogues |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015978 Therapeutic agents for ocular hypertension |
| 01/19/2012 | US20120015977 Quinolinone derivatives useful for the treatment of cns disorders |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015974 Imidazopyridine inhibitors of iap |
| 01/19/2012 | US20120015973 Mek mutations conferring resistance to mek inhibitors |
| 01/19/2012 | US20120015972 Indolizine derivative and use thereof for medical purposes |
| 01/19/2012 | US20120015971 Ophthalmic composition comprising ascomycin |
| 01/19/2012 | US20120015970 New azacyclic compounds |
| 01/19/2012 | US20120015969 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/19/2012 | US20120015968 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper-and sterile alpha motif-containing kinase (zak) |
| 01/19/2012 | US20120015967 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015965 Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy] phenyl]-6-[5[[[2-(methylsulfonyl) ethyl]amino]methyl]-2-furyl]-4- quinazolinamine |
| 01/19/2012 | US20120015964 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/19/2012 | US20120015963 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| 01/19/2012 | US20120015962 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS |
| 01/19/2012 | US20120015961 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
| 01/19/2012 | US20120015960 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 01/19/2012 | US20120015959 Heterocyclic compounds as autotaxin inhibitors |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015956 Deuterium-enriched dasatinib |
| 01/19/2012 | US20120015955 F, G, H, I and K Crystal Forms of Imatinib Mesylate |
| 01/19/2012 | US20120015954 Therapeutic agents useful for treating pain |
| 01/19/2012 | US20120015953 Methods and compositions for the treatment of allergy |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015951 Polymorphs of Brimonidine Pamoate |
| 01/19/2012 | US20120015950 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 01/19/2012 | US20120015949 Composition and method of decreasing renal ischemic damage |
| 01/19/2012 | US20120015947 Cyclic hydroxylamine as psychoactive compounds |
| 01/19/2012 | US20120015945 Use of cb1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015943 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015942 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015941 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds |
| 01/19/2012 | US20120015940 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/19/2012 | US20120015939 Topical treatment of neuropathic pain and methods of diagnosis |
| 01/19/2012 | US20120015938 1,4-benzodiazepin-2-on derivatives |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015936 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs |
| 01/19/2012 | US20120015935 Substituted Tetrahydropyrazolo-Pyrido-Azepine Compounds |
| 01/19/2012 | US20120015934 Cyclopamine lactam analogs and methods of use thereof |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015932 Pyrazole Derivatives Used as CCR4 Receptor Antagonists |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015930 Substituted imidazoheterocycle derivatives |
| 01/19/2012 | US20120015929 Novel compounds as cannabinoid receptor ligands |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015927 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015925 Novel benzothiazepine and benzothiepine compounds |
| 01/19/2012 | US20120015924 Spray-drying process |
| 01/19/2012 | US20120015923 Use of andrographolide compounds for treating inflammation and airway disorders |
| 01/19/2012 | US20120015922 Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd) |
| 01/19/2012 | US20120015921 Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015919 Therapies for treating cancer using combinations of cox-2 inhibitors and aromatase inhibitors or combinations of cox-2 inhibitors and estrogen receptor antagonists |
| 01/19/2012 | US20120015918 Lipolytic Methods for Regional Adiposity |
| 01/19/2012 | US20120015917 Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy |
| 01/19/2012 | US20120015916 Method for Treating Secondary Hyperparathyroidism in CKD |
| 01/19/2012 | US20120015915 Formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | US20120015914 Formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | US20120015913 Formulations of 14-EPI-Analogues of Vitamin D |
| 01/19/2012 | US20120015912 Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| 01/19/2012 | US20120015911 Method and compositions for treating amyloid-related diseases |
| 01/19/2012 | US20120015909 Mao-b inhibitors useful for treating obesity |
| 01/19/2012 | US20120015908 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | US20120015906 Uses of bortezomib in predicting survival in multiple myeloma patients |
| 01/19/2012 | US20120015905 Compounds for the prevention and treatment of cardiovascular diseases |
| 01/19/2012 | US20120015904 Biomarkers for diagnosis of transient ischemic attacks |
| 01/19/2012 | US20120015903 PHARMACEUTICAL COMPOSITION FOR INHIBITING INCREASE OF IgA |
| 01/19/2012 | US20120015902 Arabinoxylo-oligosaccharides useful against gastrointestinal infections |
| 01/19/2012 | US20120015901 Methods and preparations for protecting critically ill patients |
| 01/19/2012 | US20120015900 Cobalamin Taxane Bioconjugates |
| 01/19/2012 | US20120015899 Modified plant virus particles and uses therefor |
| 01/19/2012 | US20120015898 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/19/2012 | US20120015897 Novel formulation for treating fungal infections |
| 01/19/2012 | US20120015896 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative |
| 01/19/2012 | US20120015895 Use Of RR/SR-Ractopamine |
| 01/19/2012 | US20120015893 Formulations containing sorbitan carboxylic acid ester |
| 01/19/2012 | US20120015878 Use of adnf polypeptides for treating anxiety and depression |
| 01/19/2012 | US20120015875 Use Of Oxandrolone In The Treatment Of Burns And Other Wounds |
| 01/19/2012 | US20120015874 Novel inhibitors of retroviral reverse transcriptace |
| 01/19/2012 | US20120015866 Prodrugs of Heteraromatic Compounds |
| 01/19/2012 | US20120015865 Novel class of cationic lipids for transporting active agents into cells |
| 01/19/2012 | US20120015402 Method of Proliferating Plasma Cells |
| 01/19/2012 | US20120015331 Scaffold |
| 01/19/2012 | US20120015053 Treatment of psoriasis |
| 01/19/2012 | US20120015052 P2x3 receptor antagonists for treatment of pain |
| 01/19/2012 | US20120015050 Methods and materials for assessing loss of heterozygosity |
| 01/19/2012 | US20120015049 Microrna biomarker in cancer |
| 01/19/2012 | US20120015045 Functionalized fullerenes as antifungal agents |
| 01/19/2012 | US20120015042 Rna sequence-specific mediators of rna interference |
| 01/19/2012 | US20120015039 Sustained release of nutrients in vivo |
| 01/19/2012 | US20120015038 Enterically coated cysteamine, cystamine and derivatives thereof |